drugset / Trial / NCT02880995
[18 Fluorine(F)]DOPA Determinants and Predictors of Treatment Response in Psychosis
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The first purpose of this study is to determine if dopamine synthesis capacity is significantly lower in treatment non-responders from illness onset relative to treatment responders. And the second purpose of this study is to determine the potential of \[18 fluorine(F)\]-DOPA to be used to predict treatment response to antipsychotic treatment in first episode psychosis.
Timeline
- Start
- 2017-11-01
- Primary completion
- 2019-12
- Completion
- 2019-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amisulpride | Small molecule | — | — |